Strategy Forecast, price target & analysts
Strategy Target price 2026 - Analyst rating & recommendation
Strategy Classifications & Recommendation
Strategy Price Target
| Target Price | $210.80 |
| Price | $161.61 |
| Potential | 30.44% |
| Number of Estimates | 21 |
| 21 Analysts have issued a price target Strategy 2027 . The average Strategy target price is $210.80. This is 30.44% higher than the current stock price. The highest price target is $677.25 319.06% , the lowest is $126.25 21.88% . | |
| A rating was issued by 26 analysts: 23 Analysts recommend Strategy to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Strategy stock has an average upside potential 2027 of 30.44% . Most analysts recommend the Strategy stock at Purchase. |
Sales and Margin forecast 2026, 2027 & 2028
22 Analysts have issued a sales forecast Strategy 2026 . The average Strategy sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Strategy EBITDA forecast 2026. The average Strategy EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
22 Strategy Analysts have issued a net profit forecast 2026. The average Strategy net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
22 Analysts have issued a Strategy forecast for earnings per share. The average Strategy EPS is
This results in the following potential growth metrics and future valuations:
Current Strategy Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| B. Riley Securities |
Buy
➜
Buy
|
Unchanged | Sep 22 2026 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Sep 15 2026 |
| Canaccord Genuity |
Buy
➜
Buy
|
Unchanged | Sep 08 2026 |
| B. Riley Securities |
Buy
➜
Buy
|
Unchanged | Sep 03 2026 |
| Alliance Global Partners |
➜
Buy
|
Initiated | Sep 02 2026 |
| Bernstein |
Outperform
➜
Outperform
|
Unchanged | Aug 26 2026 |
| Canaccord Genuity |
Buy
➜
Buy
|
Unchanged | Aug 25 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
B. Riley Securities:
Buy
➜
Buy
|
Sep 22 2026 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Sep 15 2026 |
|
Unchanged
Canaccord Genuity:
Buy
➜
Buy
|
Sep 08 2026 |
|
Unchanged
B. Riley Securities:
Buy
➜
Buy
|
Sep 03 2026 |
|
Initiated
Alliance Global Partners:
➜
Buy
|
Sep 02 2026 |
|
Unchanged
Bernstein:
Outperform
➜
Outperform
|
Aug 26 2026 |
|
Unchanged
Canaccord Genuity:
Buy
➜
Buy
|
Aug 25 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
